Oklahomabrave
Anytime Now Frankie...
Wonder if the White Sox would trade Omar Narvaez. Put up 2 WAR in about 90 games at catcher last year. Seems to have good on base skills.
"Assuming" is a terribly BIG word.
As for Sale, go back to the time of the trade and find someone who didn't call it an overpay.
Wonder if the White Sox would trade Omar Narvaez. Put up 2 WAR in about 90 games at catcher last year. Seems to have good on base skills.
This simply isn't true. The prospect valuation charts and trade value equations bake in the risk associated with prospects. When Acuna was the top prospect in baseball, he was worth ~80 dollars in surplus value. That is assuming an average WAR outcome of ~16 over his first 6 seasons along with the likelihood of him producing less than that or more than that. Now that we have more information on Acuna, his trade value is much higher than it was when he was a prospect so there is more certainty.
And they hit the Chris Sale trade pretty close to the mark. The Red Sox really didn't overpay. They paid about ~140 million in surplus value for 3 years of a 6 win pitcher on a 39 million dollar contract... that is about right.
part of the argument in trading at least SOME of these arms now is that their value likely has nowhere to go but down.
which ones have nowhere to go but down in value
which ones have nowhere to go but down in value
Seems to me there is some reshuffling every year. Among our top prospects at the start of 2018, I would say the following have seen an increase in their market value: Acuna, Toussaint, Wilson, Pache, Waters, Contreras, Muller, Anderson, Fried.
And the following have seen a decrease: Gohara, Soroka, Allard, Wright, Wentz.
Riley has held steady.
It was a good year in the sense that more guys gained value than lost value.
As for what 2019 holds, we can try to guess. I would say Soroka and Gohara have a good chance to regain some of the lost value. I think Anderson and Toussaint might be a bit overvalued at this point. Those would be my guesses for the most likely risers and fallers in the upcoming year.
Newk and Fried for Bumgarner would probably be an overpay but you'd get a comp pick if he walks so you'd be getting a top 30-40 player in the draft for him.
What happens if Newk doesnt progress much and Fried keeps having injury issues but i dont think it would cost both of them to get Bumgarner. Not even Hamels or Verlander cost that much in value when they were traded.
Bumgarner would make sense if the trade was fair. Not sure if AA tries to trade for a top pitcher with other needs out there.
Big assumption he would pitch well enough in 2019 to justify a qualifying offer. That's very optimistic.
Like I said, the risk is baked into the projections. They all have a percentage of likelihood that he'll either fail to some extent or succeed to an extent beyond the projected 16 number. The 16 WAR number is just the average outcome for prospects of a certain stature. The risk of deviating from that number is baked in inherently. You're not correct when you say that these valuations are based only on the absolute best case scenario. That would be a pretty stupid way to evaluate prospect value. If that were the way it was done, Acuna's projected WAR baseline would have been more like 30 WAR or something nuts like that.
Sometimes I think you deliberately read around the stuff you don't like, pick out one word that is perhaps sloppily written, and use that to somehow prove a conclusion that you've already arrived at.
As for the Sale deal, there may have been circumstances that lead to people calling that trade an overpay. I don't know what they were. But as far as the valuation numbers are concerned, it fit squarely into what should have been expected. Moncada: ~80 million plus Kopech: ~40 million plus Basabe: ~15 million plus Diaz: ~5 million. That is right at the 140 million dollar mark, which was perfectly fair value for Sale.
Newk and Fried for Bumgarner would probably be an overpay but you'd get a comp pick if he walks so you'd be getting a top 30-40 player in the draft for him.
What happens if Newk doesnt progress much and Fried keeps having injury issues but i dont think it would cost both of them to get Bumgarner. Not even Hamels or Verlander cost that much in value when they were traded.
Bumgarner would make sense if the trade was fair. Not sure if AA tries to trade for a top pitcher with other needs out there.
You're wasting your breath trying to discuss logic or math with clvderp...trust me.
I wouldn't call it "very optimistic" but its definitely uncertain. But I would guess you have a greater than 50% of getting that comp pick.
If he's healthy and repeats his performance from the last two seasons, he's going to get 3-4 years from somebody, I think. Might not be at 18 AAV, but enough annually to where he's not going to take QO.
Big assumption he would pitch well enough in 2019 to justify a qualifying offer. That's very optimistic.
Plus Barraclough!Nationals are finalizing a deal to sign Trevor Rosenthal...should be cheap and a good get for them
So far they have brought back their closer and now added Rosenthal
I would call it very optimistic in light of his performances the past two seasons. He's not a TOR anymore.
Anibal Sanchez 2018 FIP 3.62.
Madison Bumgarner 2018 FIP 3.99.